Medline Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	48,028	34,104	-	-	-
Enterprise Value	58,397	53,198	0	0	0
Last Close Price	36.56	42.00	-	-	-
PS Ratio	1.65	1.20	-	-	-
PB Ratio	2.74	3.18	-	-	-
P/TBV Ratio	2.74	3.17	-	-	-
P/FCF Ratio	48.22	26.29	-	-	-
P/OCF Ratio	32.58	19.56	-	-	-
EV/Sales Ratio	2.00	1.87	-	-	-
EV/EBITDA Ratio	19.18	16.51	-	-	-
EV/EBIT Ratio	28.82	24.05	-	-	-
EV/FCF Ratio	58.63	41.02	-	-	-
Debt / Equity Ratio	0.65	0.65	0.99	0.97	-
Debt / EBITDA Ratio	4.08	3.90	5.28	7.50	-
Debt / FCF Ratio	12.22	9.69	11.66	11.71	-
Net Debt / Equity Ratio	0.92	0.99	1.01	0.89	-
Net Debt / EBITDA Ratio	3.36	3.30	5.22	6.80	-
Net Debt / FCF Ratio	10.05	8.19	11.52	10.61	-
Asset Turnover	0.75	0.76	0.71	1.29	-
Inventory Turnover	4.51	4.53	4.48	9.10	-
Quick Ratio	2.33	2.20	1.40	2.12	-
Current Ratio	4.41	4.29	3.39	4.13	-
Return on Equity (ROE)	5.56%	6.46%	7.16%	2.76%	-
Return on Assets (ROA)	4.76%	5.51%	5.73%	6.13%	-
Return on Invested Capital (ROIC)	5.39%	6.07%	6.27%	6.81%	-
Return on Capital Employed (ROCE)	5.69%	6.36%	6.36%	7.35%	-
FCF Yield	2.07%	3.80%	-	-	-
Dividend Yield	-	1.52%	-	-	-
Payout Ratio	-	44.69%	126.50%	48.72%	-92.00%
Total Shareholder Return	-	1.52%	-	-	-

SEC Filings: 10-K · 10-Q